18 lines
983 B
Markdown
18 lines
983 B
Markdown
|
file:: [s13246-023-01266-z_FLASH_meta_study_1704658773663_0.pdf](../assets/s13246-023-01266-z_FLASH_meta_study_1704658773663_0.pdf)
|
||
|
|
file-path:: ../assets/s13246-023-01266-z_FLASH_meta_study_1704658773663_0.pdf
|
||
|
|
|
||
|
|
- A major omission in many publications is a solid reporting on dosimetry and quality control
|
||
|
|
ls-type:: annotation
|
||
|
|
hl-page:: 28
|
||
|
|
hl-color:: yellow
|
||
|
|
id:: 659b077e-8b51-4d4b-b5f1-35d08f4f33f5
|
||
|
|
- Future work focusing on which dose rates, irradiation times, reactive species, and biochemical conditions optimally promote a beneficial particle-FLASH effect will contribute greatly towards progression of this phenomenon into clinica
|
||
|
|
ls-type:: annotation
|
||
|
|
hl-page:: 28
|
||
|
|
hl-color:: yellow
|
||
|
|
id:: 659b083d-a051-48cf-a962-ad08737f1311
|
||
|
|
- However, there are several areas which must be understood before this treatment modality can be translated safely in clinical setting
|
||
|
|
ls-type:: annotation
|
||
|
|
hl-page:: 28
|
||
|
|
hl-color:: yellow
|
||
|
|
id:: 659b0870-2609-4ae6-ad6f-f179225fb80d
|